Clinical trial
Selegiline for Smoking Cessation - 1
NCT00439413 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00439413 |
|---|---|
| Title | Selegiline for Smoking Cessation - 1 |
| Official title | Phase 2, Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System (STS) as an Aid for Smoking Cessation. |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | VA Office of Research and Development U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nicotine Dependence |
| Intervention type | Behavioral, Drug |
| Interventions | Selegiline Transdermal Patch, Placebo, Smoking Cessation Counseling |
| Enrollment | 246 |
| Start date | Jun 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Feb 23, 2007 |
| Last update posted | Feb 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: